Evidence map›Paper›PMID 12451080›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2002

Pharmaceutical cost containment with reference-based pricing: time for refinements.

Sebastian Schneeweiss, Malcolm Maclure, Colin Dormuth, Jerry Avorn

Abstract read
PubMed Full text at PMC
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Does knowledge of medication prices predict physicians' support for cost effective prescribing policies.The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique · 2008
    Article
  3. Article
  4. Reference-based refinements.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2003
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Sebastian SchneeweissDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass 02115, USA. schneeweiss@post.harvard.edu
Malcolm Maclure
Colin Dormuth
Jerry Avorn

Funding

CONSEQUENCES OF DRUG COST SHARING IN THE ELDERLYR01HS010881 · AHRQ · BRIGHAM AND WOMEN'S HOSPITAL · PI SCHNEEWEISS, SEBASTIAN G. · 2000 to 2006
$263k
Evaluating Drug Benefit Policy Changes in the ElderlyR03AG019463 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SCHNEEWEISS, SEBASTIAN G. · 2001 to 2001
$85k
AHRQ HHS HS10881AHRQ HHS R01 HS010881NIA NIH HHS AG19463
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health PolicyBritish ColumbiaCost ControlCosts and Cost AnalysisDrug CostsHumansReference Values

Identifiers

PMID12451080
PMCPMC134136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.